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ABSTRACT 
 
Brain activity and connectivity 
in rat model of autism induced by 
prenatal exposure to valproate 
 
Hojin Cho 
 
Department of Medical Science 
The Graduate School, Yonsei University 
 
(Directed by Professor Chul Hoon Kim) 
 
 
 
Autism spectrum disorder (ASD) is a severe lifelong neurodevelopmental 
disorder characterized by early-onset impairments in social communication and 
social interaction, and restrictive and repetitive behavior, interests, or activities. 
Currently no biological markers are available to make a reliable diagnosis of ASD. 
I used valproic acid (VPA) rat model to explore the possible alterations in 
metabolic brain activity and connectivity. Female Sprague Dawley rats were 
given a single intraperitoneal injection of sodium valproate or normal saline on 
embryonic day 12.5. To evaluate autistic-like behaviors in pups, social interaction 
was examined during postnatal weeks 4-6 using three-chamber social approach 
test. Resting-state 18F-fluorodeoxyglucose (FDG) positron emission tomography 
(PET) scans were acquired at postnatal weeks 6 or 62. To assess the changes in 
metabolic brain activity by VPA treatment, Statistical Parametric Mapping (SPM) 
was performed. I also examined if change in metabolic brain connectivity was 
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accompanied with alterations of regional metabolic activity. Metabolic 
connectivity was modeled using both conventional correlation analysis, and 
sparse inverse covariance estimation (SICE), a partial correlation analysis. VPA-
treated rats exhibited impairments in social behaviors, and this difference was 
more pronounced in male than female rats. Preference for social novelty was 
impaired in VPA-treated male rats, while sociability was diminished in VPA-
treated female rats. I found that metabolic activity and connectivity was 
significantly changed by VPA treatment. Changes in metabolic connectivity was 
revealed by SICE while conventional correlation analysis did not show any 
difference. VPA-treated male rats had significantly decreased metabolic activity 
in the olfactory bulb, and had decreased metabolic connectivity between the left 
insular cortex and left amygdala, which constitute the salience network. There 
were no brain regions with decreased metabolic activity in VPA-treated female 
rats. In contrast, VPA-treated female rats had reduced metabolic connectivity 
between the thalamus and midbrain, and between the right medial prefrontal 
cortex and left caudoputamen. Such alterations in metabolic activity and 
connectivity may represent neurobiological substrates of autistic-like behavior, 
particularly in males, and may serve as a pathognomonic sign in VPA rat models 
of ASD. As such this study supports the idea that non-invasive brain imaging may 
serve as an imaging endophenotype that could aid diagnosis of ASD, 
classification of severity, and possibly reveal insights to neurobiological 
underpinnings in autistic-like behavior. 
 
 
 
 
 
 
Key words : autism spectrum disorder, rat, valproic acid, metabolic connectivity, 
fluorodeoxyglucose, positron emission tomography, sparse inverse covariance estimation
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I. INTRODUCTION 
Autism spectrum disorder (ASD) is a severe lifelong neurodevelopmental 
disorder characterized by early-onset impairments in social communication and 
social interaction, and restrictive and repetitive behavior, interests, or activities.1 
ASD is one of the most common disorders among children. According to 
estimates released by the Centers for Disease Control and Prevention, ASD 
affects one in 68 children. ASD is five times more prevalent in boys than in girls.2 
Early diagnosis is essential for early intervention, which provides the opportunity 
for optimal development and greatly improves prognosis.3,4 However, ASD 
comprises a highly heterogeneous set of disorders, which poses a considerable 
challenge to make an accurate diagnosis, especially in preverbal children.5 The 
variable manifestations of ASD stem from the level of functioning and 
comorbidity, also renders the diagnosis difficult.6 As there are no reliable 
biological markers for ASD, the diagnosis is made based on behavioral signs and 
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symptoms. There is no single known cause for ASD. Both the genetic and 
environmental factors are thought to play roles in the development of ASD.7 
Valproic acid (VPA) is one of the most commonly prescribed teratogenic 
drugs in women of child bearing potential. It is used for the treatment of epilepsy 
and other neuropsychological disorders. VPA has been shown to increase in brain 
concentration of gamma-aminobutyric acid (GABA), the major inhibitory 
neurotransmitter.8 The mechanism of action of VPA has also been attributed to 
the direct inhibition of voltage-gated sodium channel and negative modulation of 
glutamatergic signaling. It was also demonstrated that VPA acts as a nonselective 
histone deacetylase (HDAC) inhibitor, and this contributes to the teratogenic 
effects of VPA.9 
Prenatal exposure to VPA is known to be associated with increased risk of 
ASD in human.10,11 Fetal valproate exposure in rodent showed brain 
abnormalities similar to those found in patients with ASD: reduced in neuron 
number in the oculomotor, trigeminal, abducens, and hypoglossus nerves; and 
small cerebellum with decreased number of Purkinje cells. Rats prenatally 
exposed to VPA displayed reduced social interaction, increased 
repetitive/stereotyped behaviors, and early signs of neurodevelopmental delay.12 
The VPA rat model has been shown to have construct validity, face validity, and 
predictive validity.13 However, it remains unclear how VPA exposure leads to 
neurobiological alterations responsible for the development of autistic-like 
behaviors. 
A growing body of evidence supports the notion that ASD is associated with 
altered brain connectivity.14 Decreases in white matter integrity and impaired 
long-range connectivity are well known findings in humans with ASD.15,16 
However, the connectivity changes associated with such findings and their 
relation to the behavioral phenotypes of ASD are still uncertain.17-19 Furthermore, 
findings from neuroimaging studies are largely inconsistent and even 
contradictory across studies.18,20 This may be due to the heterogeneous nature of 
5 
 
subtypes and origins of the disorders studied. Thus, a well-controlled study 
investigating changes in neural circuitry in a homogeneous type of ASD would 
reveal a more concrete relation between autistic-like behaviors and 
neurobiological alterations. 
In addition to heterogeneity, a strong male predominance has been observed 
in ASD, which affects boys five times more frequently than girls.2 This difference 
in prevalence between boys and girls is thought to arise from less pronounced 
repetitive and stereotyped behaviors in girls and dissimilar levels of functioning 
between boys and girls, or male biased diagnostic criteria, and social and cultural 
expectations.21,22 Sex-specific differences are thought to potentiate risk in males 
and/or attenuate risk in females induced by genetic and environmental factors.2 
However, little attention has been paid to how ASD in males differs from that in 
females, particularly with how differences in neurobiology may underlie 
differences in behavior. Although VPA is known to affect rats in a sex-specific 
way,23 no clear neurobiological mechanism underlying this difference has been 
identified. 
In the present study, I explored alterations in the brain connectivity of VPA-
treated and control rats using resting-state 18F-fluorodeoxyglucose (FDG) 
positron emission tomography (PET). Functional connectivity refers the temporal 
correlation of the activities among distinct brain regions. It is generally inferred 
from blood oxygenation level-dependent (BOLD) functional magnetic resonance 
imaging (fMRI) or electro- or magnetoencephalogram (EEG/MEG).24 In 
particular, BOLD fMRI has received much attention after the discovery of 
spatially organized low-frequency spontaneous fluctuations in the absence of 
explicit task.25,26 Recent investigations regarding brain circuitry have begun to 
utilize resting-state functional connectivity mapping with fMRI in animals.27 
However, unlike studies involving humans, animal studies using resting-state 
fMRI inevitably require sedation of animals, which limits exploration of resting-
state functional connectivity.28 In contrast, 18F-FDG uptake reflects activity in the 
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awake state since animals are sedated after the completion of 18F-FDG 
distribution during the resting state. Furthermore, regional 18F-FDG uptake can 
be considered a more direct measure of neuronal activity BOLD signals in fMRI, 
as neurons exhibit preferential uptake of glucose in an activity-dependent 
manner.29 In contrast, the BOLD signal is an indirect measure of neural activity. 
It depends on the change in concentration of deoxyhemoglobin in the 
microvasculature, and is affected by cerebral blood flow (CBF), cerebral blood 
volume (CBV), and cerebral blood oxygen consumption (CMRO2) in relation to 
neural activity.30,31 Although 18F-FDG PET images do not provide time series data 
for the conventional evaluation of functional connectivity, introduction of cross-
sectional analysis of 18F-FDG PET imaging allows researchers to evaluate 
differences in both regional activity and connectivity between groups. As 18F-
FDG PET reveals neuronal activity at steady state in hourly terms, PET-based 
metabolic connectivity can be estimated by measuring regional variations of 
metabolic activity in the brain.32,33 
First I performed resting-state 18F-FDG PET in VPA-treated rats and applied 
Statistical Parametric Mapping (SPM) to explore if there were any brain regions 
with altered metabolic activity in VPA-treated rats. I also examined if change in 
metabolic connectivity was accompanied with alterations of regional metabolic 
activity. I adopted a recently proposed analysis approach for estimating inverse 
covariance, called sparse inverse covariance estimation (SICE), a group-level 
partial correlation analysis of metabolic activity, which enables a more 
comprehensive understanding of brain connectivity, as compared to conventional 
intensity-based analysis.34,35 I tested whether the metabolic connectivity 
estimated by both conventional correlation analysis and SICE can identify the 
altered brain connectivity in VPA rat model of ASD in relation to autistic-like 
behaviors.  
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II. MATERIALS AND METHODS 
1. Animals 
Animal protocols were approved by the Yonsei University College of 
Medicine Institutional Animal Care and Use Committee (IACUC). Pregnant 
Sprague-Dawley (SD) female rats (Orient Bio Inc., Gyeonggi-do, South Korea) 
were randomly assigned to receive a single subcutaneous injection of sodium 
valproate (Sigma) dissolved in saline (400 mg/kg), or saline alone on embryonic 
day 12.5 (E12.5), as previously described.36 Dams were housed individually and 
were allowed to raise their own litters. The rats were divided into two groups 
(adolescence and adulthood) based on the age at imaging. Litters in adolescent 
group were culled to four male and four female pups on postnatal day 2. Litters 
in adult group were not culled. Pups were weaned at postnatal day 21 (P21), and 
were housed with 2-3 rats in same-sex and same-treatment cages. Standard plastic 
laboratory cages were used with bedding and ad libitum access to food and water, 
handled twice a week. Animals were kept in a 12-hr light-dark schedule with 
lights on at 8:00 am, in rooms under controlled humidity and temperature. 
 
2. Pup body weight 
Body weight gain of the pup was measured weekly for 5 wk for adolescent 
group (postnatal week (PNW) 1-5), and for 31 wk for adult group (PNW 2-32). 
I used a mixed effect model to analyze the effect of VPA treatment on pup body 
weight over time. The model was built using R (version 3.2.2) and the lmer() 
function in the lme4 package (version 1.1-10). 
 
3. Three-chamber social approach test 
Three-chamber social approach test was performed as described 
previously with minor modifications.37 The test consisted of three phases. In 
the first phase (habituation), a test rat was placed in the center of the empty 
three-chamber apparatus with two small wire cages in the left or right chamber 
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to habituate for 5 min. In the second phase (sociability test), an age- and sex-
matched rat that had never been exposed to the test rat, was placed in one of 
the two wire cages. The empty wire cage was presented as a novel object. Then 
the two entrances were opened to allow the test rat in the center to freely 
explore each of the three chambers for 10 min. In the third phase (preference 
for social novelty test), the test rat was gently guided to the center chamber, 
and another age- and sex-matched novel rat was placed in the empty wire cage. 
Then the two entrances were opened to allow the test rat in the center to freely 
explore for another 10 min. All tests were performed between 9 AM and 6 PM. 
Time spent in each chamber was measured by the video tracking software 
(EthoVision XT 11.5, Noldus Information Technology, Wageningen, The 
Netherlands). In adolescent group, the test was performed on PNW4, and adult 
group test was performed on PNW6. 
 
4.  18F-FDG PET acquisition 
PET scans were performed on PNW6 in adolescent group, and on PNW62 
in adult group. All rats were deprived of food for 12-18 hr before the scanning, 
but had access to water at all times. The rats were injected intraperitoneally 
with 37 MBq of 18F-FDG under light isoflurane anesthesia. Then the rats were 
moved back to the plastic cages, and woke up immediately from anesthesia. 
The cage was placed in a quiet room with dim light for 50 min. PET scans were 
acquired on Siemens Inveon scanner (Siemens, Knoxville, TN, USA). Static 
emission scan was started at 60 min after injection under isoflurane anesthesia. 
Emission scan was acquired for 20 min, followed by 20 min of transmission 
scan. All PET scans were performed between 9 AM and 6 PM. The images 
were reconstructed using the ordered subsets expectation maximization 
(OSEM) algorithm with attenuation, scatter, and random correction. The voxel 
size was 0.776 × 0.776 × 0.796 mm. 
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5. Image processing 
Spatial processing was performed using Statistical Parametric Mapping 
(SPM8, Wellcome Department of Cognitive Neurology, London, UK). All 
reconstructed images were spatially normalized to the 18F-FDG rat brain 
template (PMOD 3.6, PMOD Technologies Ltd, Zürich, Switzerland). 
As the core symptoms of ASD and comorbidities tend to persist throughout 
the lifetime,38,39 I assumed that if there are distinct features in the brain which 
represent autistic-like behavior, the features do not vary with age as long as the 
symptoms persist. Therefore, I did not consider the effect of aging in further 
imaging analysis. 
 
6. Voxel-based statistical analyses 
Voxel-based statistical analyses were performed with SPM. Spatially 
normalized images were smoothed with a 1.6 × 1.6 × 1.6 mm3 full-width-half-
maximum (FWHM) Gaussian kernel. Proportional scaling was used for global 
normalization. For statistical inferences, an P-value < 0.05 (family-wise error 
(FWE) corrected) with an extent threshold of 50 continuous voxels was 
considered significant. 
 
7. Node definition 
The images were segmented using predefined volume of interests (VOIs) 
in PMOD software. I chose 58 anatomical VOIs that served as nodes 
throughout the brain (Table 1). 18F-FDG uptake in the VOIs was normalized to 
global brain activity. 
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Table 1. Volume of interest for connectivity estimation 
Name Abbreviation 
Motor cortex left MO-L 
Somatosensory cortex left SS-L 
Auditory cortex left AUD-L 
Visual cortex left VIS-L 
Cingulate cortex left CG-L 
Frontal association cortex left FA-L 
Medial prefrontal cortex left MPF-L 
Orbitofrontal cortex left OF-L 
Insular cortex left INS-L 
Retrosplenial cortex left RSP-L 
Parietal association cortex left PA-L 
Olfactory bulb left OB-L 
Anterodorsal hippocampus left HA-L 
Posteroventral hippocampus left HP-L 
Entorhinal cortex left ENT-L 
Amygdala left AMG-L 
Caudoputamen left CP-L 
Nucleus accumbens left ACB-L 
Septum left S-L 
Thalamus left TH-L 
Hypothalamus left HY-L 
Superior colliculus left SC-L 
Inferior colliculus left IC-L 
Midbrain left MB-L 
Periaqueductal gray left PAG-L 
Ventral tegmental area left VTA-L 
Pons left P-L 
Medulla left M-L 
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Cerebellum left CB-L 
Motor cortex right MO-R 
Somatosensory cortex right SS-R 
Auditory cortex right AUD-R 
Visual cortex right VIS-R 
Cingulate cortex right CG-R 
Frontal association cortex right FA-R 
Medial prefrontal cortex right MPF-R 
Orbitofrontal cortex right OF-R 
Insular cortex right INS-R 
Retrosplenial cortex right RSP-R 
Parietal association cortex right PA-R 
Olfactory bulb right OB-R 
Anterodorsal hippocampus right HA-R 
Posteroventral hippocampus right HP-R 
Entorhinal cortex right ENT-R 
Amygdala right AMG-R 
Caudoputamen right CP-R 
Nucleus accumbens right ACB-R 
Septum right S-R 
Thalamus right TH-R 
Hypothalamus right HY-R 
Superior colliculus right SC-R 
Inferior colliculus right IC-R 
Midbrain right MB-R 
Periaqueductal gray right PAG-R 
Ventral tegmental area right VTA-R 
Pons right P-R 
Medulla right M-R 
Cerebellum right CB-R 
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8. Connectivity estimated by correlation 
For each pair of VOIs, Pearson’s correlation coefficient was calculated in 
an inter-subject manner. Then, correlation matrix was generated for each group, 
VPA-treated and control rats in each sex. Correlation matrices for each group 
were transformed to Z scores using Fisher transformation. Permutation test was 
performed to test statistical differences between groups, followed by Fisher 
transformation. The subject labels for each group were permuted 10,000 times. 
Significant differences were determined by applying a false-discovery rate 
(FDR) threshold of 0.05. 
 
9. Connectivity estimated by sparse inverse covariance estimation 
The SICE was used to estimate metabolic connectivity structure, and 
stability approach to regularization selection (StARS) was applied to determine 
the optimal network.34,35 I adopted a constrained optimization algorithm to 
estimate the strength of connections in the graph obtained by SICE.40 To test 
statistical differences between VPA-treated and control rats, I obtained a null 
distribution by permuting subject labels and the optimal network was re-
estimated for each permuted groups. The entire subject labels were permuted 
10,000 times. A FDR threshold of 0.05 was used as significance cutoff. I 
compared the sparsity and connectivity strength in the network between groups. 
 
10. Statistical analysis 
Statistical analyses were performed using R (version 3.2.2). Unless 
otherwise specified, data were analyzed with two-tailed unpaired Student’s t-
test or Mann-Whitney U test as appropriate. I also used one-way analysis of 
variance (ANOVA) with injected 18F-FDG activity as a between-group factor. 
The null hypothesis was rejected for alpha greater than 5%. Details on 
statistical method applied in imaging analyses are described in each section. 
  
13 
 
III. RESULTS 
1. Pup body weight gain 
Rats treated with VPA had lower body weight both in adolescent and adult 
groups. I found a statistically significant effect of VPA treatment both in 
adolescent (t-value = -6.71, P < 0.001) and adult (t-value = -2.97, P = 0.004) 
groups. Post hoc analysis using two-tailed unpaired Student’s t-test or Mann-
Whitney U test showed lower body weight in VPA-treated rats on PNWs from 
1 to 5 in adolescent group in both sexes (n=8 except for VPA-treated male rats 
(n=7)) (Figure 1A). In adult group, lower body weight was seen in VPA-treated 
male rats (n=15) compared to control male rats (n=9) on PNWs 12, 21, and 28. 
VPA-treated female rats (n=11) had lower body weight compared to control 
female rats (n=11) on PNWs 11, 12, 19, 20, 22-24, 27, 31, and 32 (Figure 1B). 
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Figure 1. Prenatal exposure to VPA result in reduced body weight in rat pups. 
(A) Weight gain in adolescent group. (B) Weight gain in adult group. There was 
a significant effect of VPA treatment on body weight. VPA-treated male (n=7, 
adolescent VPA-treated male; n=15, adult VPA-treated male) and female rats 
(n=8, adolescent VPA-treated female; n=11, adult VPA-treated female) were 
lighter than controls (n=8, adolescent control male; n=9, adult control male; n=8, 
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adolescent control female; n=11, adult control female) both in adolescent and 
adult groups. Female rats were lighter than male rats. Data shown as mean and 
standard error of the mean (SEM). In each time point, data were analyzed with 
two-tailed unpaired Student’s t-test or Mann-Whitney U test as appropriate. VPA, 
valproic acid; *P < 0.05, **P < 0.01, ***P < 0.001.  
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2. Three-chamber social approach test 
VPA treatment found to have no significant effect in sociability test. Both 
in adolescent and adult group, all rats preferred to explore the first stranger (S1) 
over an empty wire cage presented as a novel object (O), irrespective of VPA 
treatment or sex (Figures 2A, B). I found that VPA-treated male rats displayed 
reduced social preference for novelty. In adolescent group, there was a trend 
that VPA-treated male rats spent less time with the second stranger (S2) 
compared to controls, however VPA-treated male rats still spent significantly 
more time with the S2 than with the S1, as controls do (Figure 2C). In adult 
group, control male rats preferred to spend more time with the S2 over S1. In 
contrast, the preference to the S2 over S1 was absent in VPA-treated male rats 
(Figure 2D). VPA-treated female rats in adolescent group showed preference 
to the S1 over S2, while control female rats did not show preference to the S1 
(Figure 2C). As all adult female rats had preference to the S2 over S1, there 
was no significant effect of VPA treatment (Figure 2D). In brief, although VPA-
treated adolescent male rats maintained preference for the S2 over S1, VPA-
treated male rats showed autistic-like behaviors in general. 
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Figure 2. Sociability or social preference for novelty was impaired by VPA 
treatment. (A) Sociability test in adolescent group (n=8, adolescent control male; 
n=7, adolescent VPA-treated female; n=8, adolescent control female; n=8, 
adolescent VPA-treated female). (B) Sociability test in adult group (n=9, adult 
control male; n=15, adult VPA-treated male; n=11, adult control female; n=11, 
adult VPA-treated female). (C) Social preference for novelty test in adolescent 
group. (D) Social preference for novelty test in adult group. VPA treatment had 
no effect on sociability test. VPA-treated adult male rats lost preference to the S2 
over S1. VPA-treated female rats spent more time with the S1 over S2. Data 
represent mean ± SEM. Data were analyzed with two-tailed unpaired Student’s 
t-test or Mann-Whitney U test as appropriate. VPA, valproic acid; O, object; S1, 
stranger 1; S2, stranger 2; SEM, standard error of the mean. *P < 0.05, **P < 0.01, 
***P < 0.001. 
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3. Injected 18F-FDG activity 
Injected 18F-FDG activity in control males (n=17, 40.52 ± 0.40 MBq), 
VPA-treated males (n=22, 40.12 ± 0.34 MBq), control females (n=19, 40.48 ± 
0.35 MBq), and VPA-treated females (n=19, 40.48 ± 0.31 MBq) were not 
differed across groups. All values are mean ± standard error of the mean (SEM). 
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Figure 3. Injected 18F-FDG activity did not differ between all four subgroups. 
Injected dose in control males (n=17), VPA-treated males (n=22), control females 
(n=19), and VPA-treated females (n=19) were not different across groups. Data 
represent mean ± SEM. Data were analyzed with one-way ANOVA. VPA, 
valproic acid; SEM, standard error of the mean; ANOVA, analysis of variance. 
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4. Voxel-based statistical analyses 
VPA-treated male rats (n=22) had reduced metabolism in the olfactory 
bulb compared to control male rats (n=17) at P < 0.05 corrected for family-
wise error (FWE) (Figure 4A). The metabolism in the bilateral somatosensory 
cortices, thalami, and cerebellum was increased in VPA-treated male rats than 
control male rats (Figure 4B). In VPA-treated female rats (n=19), no region 
was decreased in metabolism compared to control female rats (n=19). 
Increased metabolism was observed in the left caudoputamen and left medulla 
in VPA-treated female rats compared to control female rats (Figures 4C, D). 
Peak coordinates in Paxinos space for each cluster are shown in Table 2. 
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Figure 4. Statistical parametric mapping revealed altered brain activity by 
VPA treatment. (A) Metabolism in the olfactory bulb was decreased in VPA-
treated male rats (n=22) compared to control male rats (n=17). (B) Metabolism 
in the bilateral somatosensory cortices, caudoputamen, and cerebellum was 
increased in VPA-treated male rats. (C-D) VPA-treated female rats (n=19) had 
increased metabolism in the left caudoputamen and left medulla compared to 
control female rats (n=19). Color bar indicates t-values. Voxels survived at 
family-wise error (FWE) corrected P < 0.05 were shown. VPA, valproic acid. 
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Table 2. Brain regions with significant metabolic differences in VPA-
treated rats compared to control rats 
Region Paxinos coordinates t-value k 
 x y z   
VPA-treated male      
Decreased metabolism*      
Olfactory bulb, bilateral 1.1  5.2  -5.8  4.7  962 
Increased metabolism*      
Somatosensory cortex, left -6.7  -2.0  -3.0  5.2  597 
Somatosensory cortex, right 
and caudoputamen, right 
6.7  -1.4  -3.4  5.1  1160 
Cerebellum, bilateral -0.3  -14.0  -4.6  4.7  108 
Caudoputamen, left -4.3  -1.0  -4.6  4.5  187 
VPA-treated female      
Increased metabolism*      
Medulla, left -1.1  -13.0  -8.2  4.5  198 
Caudoputamen, left -3.3  -0.4  -4.6  4.4  64 
*Survived at family-wise error (FWE) corrected P < 0.05. VPA, valproic acid. 
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5. Connectivity estimated by correlation 
Correlation matrices for each group in both sexes were generated: control 
males (n=17), VPA-treated males (n=22), control females (n=19), and VPA-
treated females (n=19) (Figures 5A-D). Permutation test revealed that no 
connection was significantly different to show the effect of VPA treatment in 
both sexes. 
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Figure 5. Correlation analysis did not show any connectivity changes by VPA 
treatment. (A) Control males (n=17). (B) VPA-treated males (n=22). (C) Control 
females (n=19). (D) VPA-treated females (n=19). VPA, valproic acid. 
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6. Connectivity estimated by sparse inverse covariance estimation 
I estimated the most robust and stable connections using SICE for each group, 
VPA-treated and control rats in both sexes (Figures 5A-D). There was no 
significant difference in total number of connections in the brain between VPA-
treated and control rats in both sexes. The number of connections within each 
hemisphere and between hemispheres were also not differed between VPA-
treated and control rats in both sexes (Table 3). 
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Figure 6. SICE identified connectivity changes by VPA treatment. (A) Control 
males (n=17). (B) VPA-treated males (n=22). (C) Control females (n=19). (D) 
VPA-treated females (n=19). SICE, sparse inverse covariance estimation; VPA, 
valproic acid. 
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Table 3. Number of connections in whole brain, within each hemisphere, and 
between hemispheres 
 Number of connections P 
 Control VPA-treated  
Male    
Whole brain 60 51 0.515 
Within left cerebral hemisphere 8 10 0.284 
Within right cerebral hemisphere 7 10 0.242 
Between cerebral hemispheres 18 24 0.174 
Female    
Whole brain 84 69 0.310 
Within left cerebral hemisphere 10 8 0.401 
Within right cerebral hemisphere 9 8 0.438 
Between cerebral hemispheres 33 24 0.151 
Data were analyzed using permutation test. VPA, valproic acid. 
  
28 
 
7. Node degree 
VPA-treated male rats and control male rats were not differed in node degree. 
In VPA-treated female rats, the number of connections involving the left thalamus 
was significantly increased than in control female rats (Table 4 and Figure 7). No 
node with decreased number of connections was found in VPA-treated female rats 
compared to control female rats. 
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Table 4. Changes in node degree in VPA-treated female rats 
Node Number of connections P 
 Control female VPA-treated female  
Thalamus, left 0 3 <0.001 
Data were analyzed using permutation test. VPA, valproic acid. 
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Figure 7. Aberrant number of connections was found in VPA-treated female 
rats. (A) Control females (n=19). (B) VPA-treated females (n=19). Compared to 
control females, VPA-treated female rats had an increased number of connections 
in the left thalamus. Data were analyzed using permutation test. MB, midbrain; TH, 
thalamus; VPA, valproic acid; L, left; R, right. 
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8. Connectivity strength 
In VPA-treated male rats, the connectivity strength between the left insular 
cortex and left amygdala was significantly reduced than in control male rats, 
which is important in salience processing.41 The connectivity strength between 
the left pons and left medulla, and between the right nucleus accumbens and right 
hypothalamus were increased in VPA-treated male rats compared to control male 
rats. VPA-treated female rats had decreased connectivity strength between the 
thalamus and midbrain, bilaterally, and between the right medial prefrontal cortex 
and left caudoputamen compared to control female rats. The connectivity strength 
between the right medial prefrontal cortex and right caudoputamen, and between 
the right somatosensory cortex and right hypothalamus were increased in VPA-
treated female rats (Table 5 and Figure 8) 
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Table 5. Changes in connectivity strength by VPA treatment 
Comparisons Connectivity strength P 
Connections 
VPA-
treated  
Control  
 
VPA-treated males < Control males    
Insular cortex, left ↔ Amygdala, left 0 1.96 0.001 
VPA-treated males > Control males    
Pons, left ↔ Medulla, left 0 -2.61 <0.001 
Nucleus accumbens, right ↔ 
Hypothalamus, right 
0 -2.55 <0.001 
    
VPA-treated females < Control females    
Thalamus, right ↔ Midbrain, right -1.61 0 <0.001 
Thalamus, left ↔ Midbrain, left -0.93 0 0.001 
Medial prefrontal cortex, right ↔ 
Caudoputamen, left 
0 3.33 0.001 
VPA-treated females > Control females    
Medial prefrontal cortex, right ↔ 
Caudoputamen, right 
0 -4.52 <0.001 
Somatosensory cortex, right ↔ 
Hypothalamus, right 
2.08 0 0.002 
VPA, valproic acid. 
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Figure 8. VPA treatment results in significant changes in connectivity strength. 
(A) In VPA-treated male rats (n=22), the connection between the left insular cortex 
and left amygdala was impaired compared to control males (n=17). (B) The 
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connections between the left pons and left medulla, and between the right nucleus 
accumbens and right hypothalamus were decreased in control male rats than in 
VPA-treated male rats. (C) VPA-treated female rats (n=19) had decreased 
connections between the thalamus and midbrain, bilaterally, and between the right 
medial prefrontal cortex and left caudoputamen compared to control female rats 
(n=19). (D) The connections between the right medial prefrontal cortex and right 
caudoputamen, and between the right somatosensory cortex and right hypothalamus 
were decreased in control female rats than in VPA-treated female rats. Data were 
analyzed using permutation test, followed by false discovery rate corrections 
(corrected P ≤ 0.05). ACB, nucleus accumbens; AMG, amygdala; CP, 
caudoputamen; HY, hypothalamus; INS, insular cortex; M, medulla; MB, midbrain; 
MPF, medial prefrontal cortex; P, pons; SS, somatosensory cortex; TH, thalamus; 
VPA, valproic acid; L, left; R, right. 
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IV. DISCUSSION 
ASD is heterogeneous in nature, and common pathognomonic signs remain 
elusive. Many neuroimaging efforts aimed at identifying commonalities in patients 
with ASD are also hampered by the vast diversity of ASD cases. Longitudinal 
follow-up studies have shown that abnormally increased brain volumes and 
accelerated rates of brain growth during early childhood were observed in only a 
small minority of children with ASD.42,43 Also, there was no significant difference 
between ASD and typical development in terms of the growth curve of total corpus 
callosum volume.44 Moreover, according to a recently conducted study with a large 
sample size, corpus callosum size was not decreased in ASD.18 Among the few 
studies that have investigated resting-state brain glucose metabolism in humans with 
ASD, there has been no consensus across 18F-FDG PET investigations. Indeed, 
some studies have observed no differences between patients with ASD and 
controls,45 while others have reported fewer positive correlations between frontal 
and parietal regions,46 or widespread hypermetabolism in individuals with ASD.47 
These studies are mostly based on regional metabolic differences, with the 
exception of one study that explored resting-state metabolic connectivity in humans 
with ASD.46 In that study, correlation analysis was used to estimate the metabolic 
connectivity among frontal cortices, parietal cortices, and subcortical structures, and 
patients with ASD showed impaired interactions between frontal/parietal regions 
and the neostriatum and thalamus. 
I suspected that these inconsistent results may stem from the heterogeneous 
nature of ASD cases. Thus, I focused on a homogeneous type of ASD induced by 
prenatal exposure to VPA. I hypothesized that alterations in functional connectivity 
would provide insight into the neurobiological basis of ASD, particularly that 
caused by VPA exposure. I also explored sex-specific changes in behavior and 
metabolic networks following homogeneous VPA treatment. I demonstrated that 
VPA-treated male rats displayed reduced social behavior, had decreased metabolic 
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activity in the olfactory bulb, and had impaired metabolic connectivity between left 
insular cortex and left amygdala compared to control male rats. 
Prenatal VPA exposure causes changes in neurodevelopmental trajectory. In 
vitro VPA exposure of chick neural crest cells resulted in loss of N-cadherin 
expression, leading to neural tube defect.48 The neural tube normally closes during 
4th weeks in the human.49 In the rat, E12.5 corresponds to this period, in which the 
neurogenesis occurs. VPA exposure in this vulnerable period results in abnormal 
neural development.50 As VPA act as a nonselective HDAC inhibitor, it can induce 
increase in synapse numbers and a robust facilitation of excitatory synapse 
maturation.51 VPA also enhance neural proliferation and promotes neurite growth, 
which in turn contributes to abnormal neural development.52,53 
VPA treatment caused reduced body weight gain in the pups. Both the VPA-
treated male and female rats had less body weight than controls. It is not clear 
whether the body weight gain is associated with autistic-like behaviors. Few studies 
have explored the body weight gain in human with ASD,54 and results from VPA-
treated rat are mixed.12,55 Further study is needed to clarify the relationship between 
VPA treatment and body weight gain. 
VPA-treated male rats in adult group lost the preference to the novel rat over 
familiar rat, while VPA-treated male rats in adolescent group maintained the 
preference, although the degree of the preference was less than that of controls. It is 
not clear whether the male rats in adolescent group will lose the preference if the 
three-chamber social approach test is performed more later. In contrast, VPA-treated 
female rats in adult group had the preference to the novel rat over familiar rat, as 
control rats do, while the preference was absent in VPA-treated female rats in 
adolescent group. The loss of preference for social novelty has not been considered 
as robust a social phenotype of ASD as the loss of sociability. Nevertheless, the loss 
of preference for social novelty may be one indicator of functionally significant 
impairment in social interaction, a core deficit in patients with ASD.1 In this regard, 
loss of preference for social novelty could be one possible aspect of this functionally 
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significant impairment. It is also of note that there are occasions when time spent in 
each chamber is not significant but sniffing time is significant.56 The behavioral 
discrepancy between VPA-treated adolescent males and adult males is needed to be 
validated, as there are multiple measures to test autistic-like behaviors in two 
symptom domains of ASD.57 
VPA-treated male rats had significantly decreased metabolism in the olfactory 
bulb. Diminished function of olfactory system has implicated both in rat and human 
with ASD. In VPA-treated male rats, nest-seeking response was delayed.12 Children 
with ASD did not showed the preference to pleasant odorants over unpleasant 
odorants. In contrast, typically developing children had the preference to pleasant 
odorants over unpleasant odorants.58 Increasing evidence supports that social 
chemosignaling is an important mediator of social interaction both in human and 
rodent, as olfaction fundamentally influences social behaviors.59,60 Given that the 
sniff response is similar between humans and rodents,61 decreased metabolism in 
the olfactory bulb may serve as a potential biomarker for ASD. However, whether 
this finding is specific to ASD or common across various neurodevelopmental 
disorders remains to be elucidated. 
Metabolism in the bilateral somatosensory cortices, caudoputamen, and 
cerebellum was increased in VPA-treated male rats. Longitudinal studies have 
shown that an increase in growth rate of striatum, which was specific to caudate 
nucleus, was correlated with repetitive behavior in humans with ASD.62,63 Right 
caudate volume also implicated in repetitive behaviors in ASD.64 Increased 
metabolism in the caudoputamen in VPA-treated male rats is in line with these 
observations. Increasing evidence supports the notion that the cerebellar region not 
only mediates motor function but also influences social processing.65 In humans 
with ASD, the cerebellum was shown to have defects early in life as core ASD 
deficits appear, especially in the vermis, which were correlated with social 
impairments.66 However, whether increase in metabolism in the cerebellum is 
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correlated with cerebellar defects in relation to ASD remains unclear. The role of 
somatosensory cortex in ASD is also needed to be explored. 
There was no significant effect of VPA in node degree in male rats. In VPA-
treated rats, the connectivity strength between the left insular cortex and left 
amygdala was significantly reduced than in control males, which suggests that VPA-
treated male rats had impaired salience processing as compared to controls. Salience 
network processes multiple stimuli perceived by the brain and determines which 
stimulus is stands out than others, and allows to show relevant behaviors. The 
insular cortex plays a central role in salience processing. The insular cortex is an 
information processing hub, and the anterior insular cortex interprets external 
sensory cue with internal bodily states. The insular cortex has extensive structural 
connections with the amygdala, orbitofrontal cortex, olfactory cortex, anterior 
cingulate cortex, and superior temporal sulcus. In particular, the activity of the 
insular cortex, often together with amygdala activity, reflects one's interoception, as 
well as the bodily perceptions of external stimuli.41 Previous studies revealed that 
altered salience network connectivity or reduced salience network integrity were 
associated with ASD core symptoms.67,68 Reduced salience processing may serve as 
a pathognomonic sign in VPA rat model of ASD. The significance of increased 
connections between the left pons and left medulla, and between the right nucleus 
accumbens and right hypothalamus, which were shown in VPA-treated males, is 
needed to be clarified. 
VPA-treated female rats had increased metabolism in the left caudoputamen 
and left medulla, had increased metabolic connectivity between the right medial 
prefrontal cortex and right caudoputamen, and between the right somatosensory 
cortex and right hypothalamus, but had decreased metabolic connectivity between 
the thalamus and midbrain, bilaterally, and between the right medial prefrontal 
cortex and left caudoputamen. Whether these regions play a significant role in the 
development of autistic-like behavior is not clear. 
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VPA-treated female rats showed less prominent behavioral derangement and 
associated changes in brain connectivity, and these findings are in line with those of 
a previous study, which indicated that VPA affects rats in a sex-specific manner.23 
Whereas women are less affected by ASD than men, women show a broad spectrum 
of clinical presentation. While women with low-functioning ASD exhibit more 
severe cognitive impairment, women with high-functioning ASD may be 
underdiagnosed or misdiagnosed.69 Such behavioral variability makes group 
comparison following VPA treatment difficult. 
The changes in brain activity and connectivity correlated with autistic-like 
behavior in the present study were lateralized rather than symmetric. Previous 
studies have also recognized abnormal brain lateralization in patients with ASD. 
Atypical cerebral asymmetry and the absence of the left hemispheric dominance for 
language has been reported as a feature in patients with ASD, although this 
alteration is not specific to ASD.70 In this study, I could not find shared features 
between changes in brain activity and connectivity. However, a number of studies 
have already shown that changes in brain activity and connectivity often accompany 
one another in patients with ASD.15 Subtle changes were possibly obscured by strict 
statistical criteria. 
My results indicated that multiple brain regions were involved in the 
development of autistic-like behavior in VPA-exposed rats. The olfactory bulb 
processes social chemosignaling.59,60 The insular cortex and amygdala constitute the 
salience network and are involved in social cognition.71,72 The cerebellum has also 
been implicated in social and emotional processing, language, and cognition.65 
Taken together, these findings suggest that inappropriate responses to social stimuli 
from deficient salience processing and abnormal social processing in the cerebellum 
contribute to autistic-like behavior. Although VPA exposure represents only one 
possible risk factor for ASD, the VPA rat model may shed light on brain alterations 
that occur during the development of ASD. 
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In a methodological aspect, brain connectivity estimated by SICE revealed 
more differences among groups compared to the estimation using conventional 
correlation analysis, as group comparison based on Pearson’s correlation analysis 
failed to show any significant differences. A fundamental issue is that the Pearson’s 
correlation method cannot factor out latent effects of a third and/or fourth node that 
may modulate connectivity between the two nodes. This makes interpretation of the 
correlative activities unclear, whether they are from the intrinsic structural 
connection or from polysynaptic induction, common modulatory effects, or 
common feed-forward projections via the thalamus.73 By its definition, inverse 
covariance measures connection between two brain regions while controlling for 
the effects from other brain regions.74 Thus, inverse covariance measures are more 
efficient in revealing direct associations between brain areas. If a covariance 
between two brain regions is considerably large and is shared by both groups, 
comparison using conventional correlation analysis may not capture the group 
differences. However, as SICE models brain connectivity at the group level, it is not 
possible to estimate brain connectivity at the individual level, limiting its use in 
aiding the diagnosis of ASD. Another limitation is that, as the number of subjects 
was not sufficient to model brain connectivity in each age group, it remains to be 
validated whether the robust brain connectivity observed in VPA-treated rats 
changes with age. Another limitation is that nodes were empirically defined based 
on anatomy. A data-driven method called independent component analysis (ICA), 
which does not require prior knowledge, may provide more appropriate chance to 
explore connectivity of the entire brain, especially in terms of substructures.75  
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V. CONCLUSION 
VPA-treated rats exhibited impairments in social behaviors, and this 
difference was more pronounced in male than female rats. Preference for social 
novelty was impaired in VPA-treated male rats, while sociability was diminished 
in VPA-treated female rats. I found that metabolic activity and connectivity was 
significantly changed by VPA treatment. Changes in metabolic connectivity was 
revealed by SICE while conventional correlation analysis did not show any 
difference. VPA-treated male rats had significantly decreased metabolic activity 
in the olfactory bulb, and had decreased metabolic connectivity between the left 
insular cortex and left amygdala, which constitute the salience network. There 
were no brain regions with decreased metabolic activity in VPA-treated female 
rats. In contrast, VPA-treated female rats had reduced connectivity between the 
thalamus and midbrain, and between the right medial prefrontal cortex and left 
caudoputamen. Such alterations in metabolic activity and connectivity may 
represent neurobiological substrates of autistic-like behavior, particularly in 
males, and may serve as a pathognomonic sign in VPA rat models of ASD. As 
such this study supports the idea that non-invasive brain imaging may serve as an 
imaging endophenotype that could aid diagnosis of ASD, classification of 
severity, and possibly reveal insights to neurobiological underpinnings in autistic-
like behavior. 
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ABSTRACT (IN KOREAN) 
 
산전 발프론산 노출 자폐 백서 모델에서의 뇌 활성 및 연결성 
 
<지도교수 김 철 훈> 
 
연세대학교 대학원 의과학과 
 
조 호 진 
 
 
 
자폐스펙트럼장애는 일생 동안 지속되는 심한 신경발생학적 장애로, 
조기에 사회적 의사소통과 사회적 상호작용에 저하가 발생하고, 
제한적이고 반복적인 행동이 나타나는 것이 특징이다. 현재 진단에 
유용한 생물학적 표지자는 알려진 것이 없다. 발프론산 백서 모델을 
사용하여 뇌 대사 및 연결성에 변화가 존재하는지 알아보았다. 암컷 
백서(female Sprague Dawley rat)에 임신 후 12.5일에 발프론산 또는 생리 
식염수를 복강 내에 주사하였다. 새끼 백서에서 자폐 행동을 
평가하기 위하여 행동 검사(three-chamber social approach test)를 생후 4-
6주에 시행하였다. 기저 상태 18F-FDG 양전자방출단층촬영(18F-
fluorodeoxyglucose positron emission tomography)을 생후 6주 또는 62주에 
시행하였고, 뇌 대사에 변화가 있는지 알아보기 위하여 SPM(Statistical 
Parametric Mapping)을 시행하였다. 또한 대사 연결성 변화가 
동반되는지 확인하였다. 대사 연결성은 전통적인 상관 분석, 그리고 
부분 상관 분석 기법인 SICE(sparse inverse covariance estimation)를 
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이용하여 분석하였다. 발프론산에 노출된 백서는 사회적 행동이 
저하되었으며, 이 차이는 암컷 백서보다 수컷 백서에서 두드러지게 
나타났다. 수컷 백서에서는 사회적 새로움 선호(preference for social 
novelty)가 감소하였고, 암컷 백서에서는 사회성(sociability)이 
감소하였다. 발프론산에 노출된 백서에서 대사 활성도 및 대사 
연결성에 변화가 나타나는 것을 확인하였다. 대사 연결성 변화는 
전통적인 상관 분석으로는 확인할 수 없었고, SICE로 확인할 수 
있었다. 발프론산에 노출된 수컷 백서에서 후각망울(olfactory bulb)에서 
대사가 유의하게 감소하였고, 현저성 망(salience network)을 구성하는 
좌도피질(left insular cortex)과 좌편도(amygdala) 사이에 대사 연결성이 
감소하였다. 발프론산에 노출된 암컷 백서에서는 대사 활성도가 
감소한 부분이 없었으나 시상(thalamus)과 중뇌(midbrain), 그리고 
우내측전전두엽피질(right medial prefrontal cortex)과 
꼬리조가비핵(caudoputamen) 사이의 대사적 연결성이 감소하였다. 
이러한 대사 활성도 및 대사 연결성 변화는 특히 남성에서 자폐 유사 
행동에 대한 신경생물학적인 기질을 대변할 수 있을 것으로 보이며, 
발프론산 노출 자폐 모델에서 질병 특유 징후로서 가능성이 있음을 
시사한다. 따라서 본 연구는 비침습적인 뇌 영상이 
자폐스펙트럼장애를 진단하고, 중증도를 분류하고, 자폐 유사 행동에 
대한 신경생물학적인 이해를 돕는 영상 내적표현형으로 역할이 
가능할 수 있음을 나타낸다. 
 
 
핵심되는 말 : 자폐스펙트럼장애, 백서, 발프론산, 대사적 연결성, 
fluorodeoxyglucose, 양전자방출단층촬영, sparse inverse covariance 
estimation  
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